OXALATE RETENTION IN END-STAGE RENAL-FAILURE (ESRF) - HEMODIALYSIS (HD) VS CHRONIC AMBULATORY PERITONEAL-DIALYSIS (CAPD) AND THE EFFECTS OF ASCORBIC-ACID AND PYRIDOXINE

被引：1

作者：

MORGAN, SH

PURKISS, P

MAHER, ER

WATTS, RWE

CURTIS, JR

机构：

[1] CLIN RES CTR,HARROW HA1 3UJ,MIDDX,ENGLAND

[2] CHARING CROSS HOSP,DEPT MED,LONDON W6 8RP,ENGLAND

来源：

CLINICAL SCIENCE | 1987年 / 73卷

关键词：

D O I：

10.1042/cs073041Pc

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：P41 / P41

页数：1

共 50 条

[41] TREATMENT OF END-STAGE RENAL-FAILURE DUE TO DIABETES-MELLITUS WITH PERITONEAL-DIALYSIS - TREATMENT OF CHOICE
PLAKSIN, J
BONER, G
ROSENFELD, JB
REVUE ROUMAINE DE MEDECINE-MEDECINE INTERNE, 1982, 20 (04): : 283 - 288
[42] ALTERATION OF PITUITARY-THYROID FUNCTION IN PATIENTS WITH CHRONIC RENAL-FAILURE TREATED BY HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
ROSS, RJM
GOODWIN, FJ
HOUGHTON, BJ
BOUCHER, BJ
ANNALS OF CLINICAL BIOCHEMISTRY, 1985, 22 (MAR) : 156 - 160
[43] COMPARISON OF THE EFFECTS OF MUZOLIMINE AND FUROSEMIDE IN PATIENTS WITH END-STAGE RENAL-FAILURE ON CHRONIC DIALYSIS
SCHMIDT, P
LOEW, D
DYCKA, J
KOPSA, H
BALCKE, P
ZAZGORNIK, J
DEUTSCH, E
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 20 (01) : 23 - 26
[44] Risk of hemodialysis against peritoneal dialysis for chronic heart failure in patients with end-stage renal disease
Kawada, Tomoyuki
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 360 - 360
[45] THE USE OF CONTINUOUS PERITONEAL-DIALYSIS IN EUROPE FOR THE TREATMENT OF CHILDREN WITH END-STAGE RENAL-FAILURE - DATA FROM THE EDTA REGISTRY
RIZZONI, G
BROYER, M
EHRICH, JHH
SELWOOD, NH
BRUNNER, FP
BRYNGER, H
DYKES, SR
FASSBINDER, W
GEERLINGS, W
TUFVESON, G
WING, AJ
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (12) : 985 - 990
[46] A COMPARISON OF EMPLOYMENT RATES OF PATIENTS TREATED WITH CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS VS IN-CENTER HEMODIALYSIS (MICHIGAN END-STAGE RENAL-DISEASE STUDY)
JULIUS, M
KNEISLEY, JD
CARPENTIERALTING, P
HAWTHORNE, VM
WOLFE, RA
PORT, FK
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (04) : 839 - 842
[47] THE INCIDENCE OF DYSLIPOPROTEINEMIA IS INCREASED IN CHILDREN WITH END-STAGE RENAL-DISEASE (ESRD) TREATED WITH PERITONEAL-DIALYSIS (PD) VERSUS HEMODIALYSIS (HD)
HEILICZER, JD
KUIZON, BD
OSORIO, MA
CLARDY, CW
PEDIATRIC RESEARCH, 1994, 35 (04) : A366 - A366
[48] ACID-BASE STATUS OF ADULTS WITH END-STAGE RENAL-DISEASE TREATED BY CHRONIC PERITONEAL-DIALYSIS
GOODKIN, DA
RAJA, RM
KIDNEY INTERNATIONAL, 1988, 33 (01) : 246 - 246
[49] BEHAVIOR OF BETA-2-MICROGLOBULIN IN PATIENTS WITH CHRONIC-RENAL-FAILURE UNDERGOING HEMODIALYSIS, HEMODIAFILTRATION AND CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD)
BLUMBERG, A
BURGI, W
CLINICAL NEPHROLOGY, 1987, 27 (05) : 245 - 249
[50] Long-term clinical effects of treatment by daytime ambulatory peritoneal dialysis with an individualized dialysis dose mode are comparable to traditional dialysis methods (hemodialysis or continuous ambulatory peritoneal dialysis) for end-stage renal failure
Zhang Zhi-yong
Li Ming-xu
Yu Yong-wu
Zhou Chun-hua
ASIAN BIOMEDICINE, 2014, 8 (01) : 67 - 73

← 1 2 3 4 5 →